Novo Nordisk says diabetes drug approved in Japan
Home page > News

Novo Nordisk says diabetes drug approved in Japan

www.reuters.com   | 28.09.2012.

COPENHAGEN (Reuters) - Denmark's Novo Nordisk A/S, the world's biggest insulin producer, said on Friday its diabetes treatment Tresiba had been approved in Japan.
br />

Novo Nordisk said in a statement it expected to launch Tresiba in the country as soon as price negotiations have been completed.

(Reporting by Copenhagen Newsroom; Editing by Matt Driskill)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>